Clinical Trial Update: Perinatal Tissue Mesenchyme Stem Cells in the Treatment for Caesarean Section Scars [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for perinatal tissue mesenchyme stem cells in treating Caesarean section scars has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Caesarean Section Scar Healing
• Cicatrix

Snippet

Sponsor: Maternal and Child Health Hospital of Foshan | Conditions: Cicatrix | Phase 2 | Status: COMPLETED